AFL vs TGTX · P/E 14, rev $4.12B vs P/E 18, rev $240.3M
Aflac Incorporated (AFL) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported AFL revenue for 2026-06-30 was $4.12B. Net income was $825.0M. Revenue was down 5.3% from 2026-03-31 to 2026-06-30. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the AFL and TGTX stock pages for the full models.
Not investment advice.